Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.

JNCI Cancer Spectr 2020 Jun 5;4(3):pkaa023. Epub 2020 Apr 5.

Division of Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Background: The American Joint Committee on Cancer staging and other prognostic tools fail to account for stage-independent variability in outcome. We developed a prognostic classifier adding Immunoscore to clinicopathological and molecular features in patients with stage III colon cancer.

Methods: Patient (n = 559) data from the FOLFOX arm of adjuvant trial NCCTG N0147 were used to construct Cox models for predicting disease-free survival (DFS). Variables included age, sex, T stage, positive lymph nodes (+LNs), N stage, performance status, histologic grade, sidedness, , mismatch repair, and Immunoscore (CD3, CD8 T-cell densities). After determining optimal functional form (continuous or categorical) and within Cox models, backward selection was performed to analyze all variables as candidate predictors. All statistical tests were two-sided.

Results: Poorer DFS was found for tumors that were T4 vs T3 (hazard ratio [HR] = 1.76, 95% confidence interval [CI] = 1.19 to 2.60;  = .004), right- vs left-sided (HR = 1.52, 95% CI = 1.14 to 2.04;  = .005), (HR = 1.74, 95% CI = 1.26 to 2.40;  < .001), mutant (HR = 1.66, 95% CI = 1.08 to 2.55;  = .02), and low vs high Immunoscore (HR = 1.69, 95% CI = 1.22 to 2.33; = .001) (all <.02). Increasing numbers of +LNs and lower continuous Immunoscore were associated with poorer DFS that achieved significance (both s<.0001). After number of +LNs, T stage, and , Immunoscore was the most informative predictor of DFS shown multivariately. Among T N tumors, Immunoscore was the only variable associated with DFS that achieved statistical significance. A nomogram was generated to determine the likelihood of being recurrence-free at 3 years.

Conclusions: The Immunoscore can enhance the accuracy of survival prediction among patients with stage III colon cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkaa023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236783PMC
June 2020

Publication Analysis

Top Keywords

molecular features
8
stage iii
8
cox models
8
iii colon
8
stage positive
4
176 95%
4
included age
4
sex stage
4
95% confidence
4
age sex
4
positive lymph
4
stage performance
4
ratio [hr]
4
performance status
4
+lns stage
4
nodes +lns
4
lymph nodes
4
[hr] 176
4
variables included
4
survival dfs
4

Similar Publications